Although AD is not caused by mutations in the MAPT gene, previous studies demonstrated that CSF biomarkers of AD differ among patients with different MAPT genotypes (Compta et al., 2011; Kauwe et al., 2008). The gene discussed is MAPT; the disease is Alzheimer disease.